Generative AI Startup Consint.AI Raises INR 5 Cr to Scale Health Tech Innovations With the fresh funds, the brand aims to scale operations, expand sales outreach, and accelerate the development of its Generative AI Feature Suite for the company's Health AI Platform.

By Entrepreneur Staff

You're reading Entrepreneur India, an international franchise of Entrepreneur Media.

Ashish Chaturvedi, Founder and CEO of Consint.AI

Generative AI-driven healthcare insurance fraud and risk management startup Consint.AI announced that it has raised INR 5 crore in a seed funding round led by Equanimity Ventures and Seafund.

The funds will be utilised to scale operations, expand sales outreach, and accelerate the development of its Generative AI Feature Suite for the company's Health AI Platform.

This advanced suite aims to enhance fraud detection, optimise claims processing, and deliver personalised clinical care, pushing the boundaries of innovation in healthcare. Additionally, the funding will enable team expansion, infrastructure upgrades, and intensified R&D efforts, reinforcing Consint.AI's position as a leader in health tech solutions.

Ashish Chaturvedi, Founder and CEO of Consint.AI, said, "This market traction and milestones highlight the transformative potential of Generative AI in reshaping healthcare as we know it. At Consint, we are pioneering platforms like CIPHR.ai and Risk.ai to address complex challenges in healthcare transactions and personalized care. This funding accelerates our mission to lead the charge in AI-powered healthcare transformation."

Founded in 2020, Consint.AI was spearheaded by Ashish Chaturvedi and later joined by co-founder Swadeep Singh. The company focuses on leveraging Generative AI to optimise healthcare claims processing and fraud detection, making healthcare transactions more affordable and efficient. Its flagship platforms, Risk.ai and CIPHR.ai, target challenges in insurance optimisation, fraud mitigation, and critical patient management.

In the past year, the startup claims to have expanded its presence across India, the Middle East, and Africa. It recently launched CIPHR.ai, an AI-driven platform designed for hospitals, which employs custom Generative AI models to revolutionise care personalisation and streamline claims generation. Tailored for emerging markets and the US Accountable Care Organization (ACO) sector, CIPHR.ai delivers intelligence at the point of care, ensuring efficiency for healthcare providers.

Consint.AI's rapid growth includes INR 10 crore in signed contracts over the last two quarters, featuring multi-year agreements with leading insurance providers and hospitals. The strong market validation underscores demand for its innovative solutions, particularly in Generative AI and Document Forensics.

Manoj Agarwal, Managing Partner at Seafund, added, "Consint.AI's focus on solving multi-billion-dollar challenges in healthcare insurance claims and fraud detection is exemplary. We are confident that our expertise and network will enable the company to achieve its ambitious goals."

Entrepreneur Staff

Entrepreneur Staff

Editor

For more than 30 years, Entrepreneur has set the course for success for millions of entrepreneurs and small business owners. We'll teach you the secrets of the winners and give you exactly what you need to lay the groundwork for success.
Business Ideas

70 Small Business Ideas to Start in 2025

We put together a list of the best, most profitable small business ideas for entrepreneurs to pursue in 2025.

Business News

Uber Released Its Annual List of Things People Leave in Backseats — and It Is Wild

The rideshare giant's annual list of items that passengers left in cars will make you shake your head — and double-check the seat before you get out.

Growing a Business

The AI Playbook Billion-Dollar Brands Are Using to Automate & Dominate (And How You Can Too)

AI isn't just a tool — it's replacing entire teams. Learn how top brands use it to run sales, ops and marketing 24/7.

News and Trends

The Ceiling Breaker: Nandini Piramal, Chairperson, Piramal Pharma Limited (PPL)

Her goals are to make Piramal Pharma a $2 billion company by 2030 while achieving a 25 per cent EBITDA margin—an aim that requires a strong focus on innovation, operational excellence, and financial discipline

Business News

Google Layoffs Affect Hundreds in Division Working on Chrome Browser, Pixel Phones

A Google spokesperson said the move would help Google run more efficiently.

Starting a Business

Stop Searching for Your Purpose — It's Delaying Your Success. Here's What to Focus on Instead.

Many entrepreneurs wait to "find" their purpose before acting — but purpose isn't found; it's built.